Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
PodcastDiscover strategies to tackle tariffs and boost business resilience through smarter sourcing, planning and risk from Kurtis Dixon and Marvin Ferguson.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Kurtis Dixon and Marvin Ferguson break down how the OBBBA reshapes bonus depreciation, R&D costs and strategies for year-end tax planning.
Success StoryWeaver created a durable environmental reporting framework for a global supplier: greenhouse gas tracking, audit readiness and sustainability.
Maximize year-end tax benefits with Kurtis Dixon and Marvin Ferguson, as they explore bonus depreciation, equipment timing and deductions.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
The OBBBA revives 100% bonus depreciation and introduces new deductions for qualified production property and manufacturing.
Explore Q2 2025 trends in Texas life sciences, from capital selectivity and pipeline constraints to market recovery and beyond.
Explore Q1 2025 trends in Texas life sciences, from capital concentration and clinical momentum to innovation and public market dynamics.
North Carolina’s top business ranking highlights the value of smart incentives and pro-growth policies for companies seeking long-term success.
Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.
